{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:17:55Z","timestamp":1783160275471,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-005630"],"award-info":[{"award-number":["INV-005630"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014204","name":"Gateway Foundation Inc Carbondale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128640","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:16:07Z","timestamp":1777749367000},"page":"128640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-effectiveness of human papillomavirus vaccination in Jordan: A modelling study"],"prefix":"10.1016","volume":"83","author":[{"given":"Ayman Ahmad Bani","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Mostafa","family":"Thneibat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Al-Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Nimer","family":"Al-Hawarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Maswadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint J.","family":"Pecenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raid Anwar","family":"Al-Shboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Bdour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128640_bb0005","author":"WHO"},{"key":"10.1016\/j.vaccine.2026.128640_bb0010","series-title":"Statistics","author":"HPV Information Centre","year":"2020"},{"key":"10.1016\/j.vaccine.2026.128640_bb0015","article-title":"Toward a framework to assess the financial and economic burden of cervical Cancer in low- and middle-income countries: a systematic review","volume":"10","author":"Fuady","year":"2024","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128640_bb0020","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1186\/s12889-021-10907-5","article-title":"Trends of cervical cancer at global, regional, and national level: data from the global burden of disease study 2019","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128640_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(16)30553-9","article-title":"HPV vaccinations: a middle eastern and north African dilemma","volume":"17","author":"Baghi","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128640_bb0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.vaccine.2026.128640_bb0035","series-title":"Jordan Human Papillomavirus and Related Cancers, Fact Sheet 2023","author":"WHO","year":"2023"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128640_bb0040","article-title":"From awareness to action: unveiling knowledge, attitudes and testing strategies to enhance human papillomavirus vaccination uptake in Jordan","volume":"10","author":"Al-Leimon","year":"2024","journal-title":"J Virus Erad"},{"key":"10.1016\/j.vaccine.2026.128640_bb0045","author":"WHO"},{"key":"10.1016\/j.vaccine.2026.128640_bb0050","unstructured":"UNICEF. Middle-Income Countries' Financing Facility. Available at: https:\/\/www.unicef.org\/supply\/middle-income-countries-financing-facility#:\u223c:text=The%20Middle%2DIncome%20Countries'%20Financing,no%20longer%20receive%20donor%20support. [Accessed 6th November 2024] 2024."},{"key":"10.1016\/j.vaccine.2026.128640_bb0055","author":"GAVI"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128640_bb0060","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s40273-020-00954-y","article-title":"Informing a cost-effectiveness threshold for health technology assessment in China: a marginal productivity approach","volume":"38","author":"Ochalek","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128640_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128640_bb0070","author":"UNIVAC"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128640_bb0075","article-title":"Impact and cost-effectiveness of alternative human papillomavirus vaccines for preadolescent girls in Mozambique: a modelling study","volume":"11","author":"Guimaraes","year":"2023","journal-title":"Vaccines (Basel)."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128640_bb0080","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1186\/s12913-023-10283-3","article-title":"Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study","volume":"23","author":"Kiendrebeogo","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2026.128640_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2022.100161","article-title":"The potential cost-effectiveness of HPV vaccination among girls in Mongolia","volume":"11","author":"Luvsan","year":"2022","journal-title":"Vaccine X"},{"issue":"29","key":"10.1016\/j.vaccine.2026.128640_bb0090","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1016\/j.vaccine.2023.05.019","article-title":"Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: a modelling study","volume":"41","author":"Mwenda","year":"2023","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.128640_bb0095","doi-asserted-by":"crossref","first-page":"A135","DOI":"10.1016\/j.vaccine.2014.12.031","article-title":"Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil","volume":"33","author":"Novaes","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.128640_bb0100","doi-asserted-by":"crossref","first-page":"A85","DOI":"10.1016\/j.vaccine.2021.07.027","article-title":"The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana","volume":"40","author":"Vodicka","year":"2022","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.128640_bb0105","doi-asserted-by":"crossref","first-page":"A174","DOI":"10.1016\/j.vaccine.2014.12.042","article-title":"Cost-effectiveness of HPV vaccination in Belize","volume":"33","author":"Walwyn","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128640_bb0110","author":"XE. 1 JOD to USD"},{"key":"10.1016\/j.vaccine.2026.128640_bb0125","series-title":"Jordan Cancer registry","author":"Department CP","year":"2023"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128640_bb0130","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","article-title":"Disability weights for the global burden of disease 2013 study","volume":"3","author":"Salomon","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128640_bb0135","author":"FIGO"},{"key":"10.1016\/j.vaccine.2026.128640_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6827384","article-title":"Trends in the incidence of cervical cancer in Jordan, 2000-2013","volume":"2017","author":"Sharkas","year":"2017","journal-title":"J Oncol"},{"key":"10.1016\/j.vaccine.2026.128640_bb0150","author":"UNICEF"},{"key":"10.1016\/j.vaccine.2026.128640_bb0155","author":"UNICEF"},{"key":"10.1016\/j.vaccine.2026.128640_bb0160","author":"UNICEF"},{"key":"10.1016\/j.vaccine.2026.128640_bb0165","author":"UNICEF"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128640_bb0170","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.vaccine.2024.01.094","article-title":"Costs of human papillomavirus vaccine delivery in low- and middle-income countries: a systematic review","volume":"42","author":"Slavkovsky","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128640_bb0175","author":"US Bureau of Labor Statistics"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128640_bb0180","article-title":"Attitude towards HPV vaccination and the intention to get vaccinated among female university students in health schools in Jordan","volume":"9","author":"Sallam","year":"2021","journal-title":"Vaccines (Basel)."},{"issue":"4","key":"10.1016\/j.vaccine.2026.128640_bb0185","first-page":"429","article-title":"A survey of Jordanian obstetricians and gynecologists\u2019 knowledge and attitudes toward human papillomavirus infection and vaccination","volume":"35","author":"Lataifeh","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.vaccine.2026.128640_bb0190","author":"WHO"},{"key":"10.1016\/j.vaccine.2026.128640_bb0195","unstructured":"Al-Shaikh Aa. 2023."},{"key":"10.1016\/j.vaccine.2026.128640_bb0200","series-title":"Sustainable immunization financing in Jordan","author":"Rauscher","year":"2023"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128640_bb0205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.21147\/j.issn.1000-9604.2023.06.11","article-title":"Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: a nationwide multicenter cross-sectional study","volume":"35","author":"Chen","year":"2023","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128640_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jval.2020.07.010","article-title":"Costs of immunization programs for 10 vaccines in 94 low- and middle-income countries from 2011 to 2030","volume":"24","author":"Sim","year":"2021","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2026.128640_bb0215","series-title":"Global HPV Prevention policy atlas","author":"Forum EP","year":"2025"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128640_bb0220","doi-asserted-by":"crossref","first-page":"27916","DOI":"10.1038\/s41598-025-13423-3","article-title":"HPV DNA screening and vaccination strategies in Tunisia","volume":"15","author":"Lahdhiri","year":"2025","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128640_bb0225","article-title":"Pervasive parental hesitancy and resistance towards measles rubella vaccination in Jordan","volume":"11","author":"Barakat","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128640_bb0230","first-page":"24","article-title":"Cervical cancer screening in Jordan; a review of the past and an outlook to the future - facts and figures","volume":"22","author":"Fram","year":"2023","journal-title":"Prz Menopauzalny"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128640_bb0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4274\/jtgga.galenos.2022.2022-6-6","article-title":"Barriers to the HPV vaccination program in the eastern Mediterranean region: a narrative review","volume":"24","author":"Hakimi","year":"2023","journal-title":"Journal of the Turkish German Gynecological Association"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:49:14Z","timestamp":1783158554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26004482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0264410X26004482"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128640","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of human papillomavirus vaccination in Jordan: A modelling study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128640"}}